Company intelligence / Profile preview
Alfa Intes
- Ownership
- Private
- Employees
- ~150
- Development stage
- Commercial
Overview
Alfa Intes is a leading Italian ophthalmological group with over six decades of experience. It operates across the value chain from R&D to manufacturing and commercialization of pharmaceuticals, medical devices, nutraceuticals, surgical equipment, and diagnostic instruments for eye care. Recent clinical studies support efficacy and safety for products like Diabec® in non-infectious uveitis complicated by macular oedema and diabetic retinopathy with macular oedema.
- Therapeutic areas
- Ophthalmology
- Modalities
- Small moleculeMedical deviceNutraceuticals
- Industry
- Biotech
Drug pipeline
7 assets6 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Alfa Intes.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Alfa Intes.